Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs Wellorithm

By GLP-1 ScorecardUpdated

Found
Site position #8

Higher grade

Wellorithm
Site position #527

Lower grade

Score comparison

Found has the higher recorded score — 83.5/100 to 48.5/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueFound +48
78
30
Dose & formulationFound +2
94
92
Clinical oversightFound +58
86
28
Labs & monitoringFound +42
82
40
FulfillmentFound +22
84
62
Contract termsFound +25
70
45
Found · top barWellorithm · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFoundWellorithm
WeighScore83.5/10048.5/100
GradeBC
Site position#8#527
Semaglutide$179 first, then $289 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)$147 first payment; $247 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed.
Tirzepatide$219 first, then $359 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)$249 first payment; $349 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed.
CoverageU.S. service with state, treatment and insurance restrictions; confirm your eligibilityAdvertises all 50 states plus D.C.; confirm the specific treatment, prescribing clinician and dispensing pharmacy for your location.
Brand-name accessYesYes
Oral / sublingualYesYes
Found

Site position #8 · B

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
Wellorithm

Site position #527 · C

Strengths

  • Publishes first and ongoing compounded injection charges separately
  • Advertises the same medication price across its listed weekly dose ranges
  • Initial consultation and shipping included in injection plan cards
  • Lists four branded options and a generic oral dissolving-tablet option; exact quote and prescription still needed

What to consider

  • Pricing says monthly renewal, while terms say billing every 28 days
  • Oral ingredient, strength, supply and price not specified in the public injection table
  • Branded pages carry inconsistent three-month/500mg footnotes; insurance service and cash-only terms need reconciliation
  • Treating Professional Entities and dispensing pharmacy unnamed in the reviewed policies
  • Consultation fee retention on clinical rejection is not quantified; processed-payment refunds are restricted

Featured provider

Found

Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard